A clinically feasible protocol of TCR gene editing to treat Multiple Myeloma without inducing GvHD

被引：0
|
作者：
Mastaglio, S. [1 ]
Genovese, P. [1 ]
Magnani, Z. [1 ]
Camisa, B. [1 ]
Landoni, E. [1 ]
Schiroli, G. [1 ]
Provasi, E. [1 ]
Lombardo, A. [1 ]
Reik, A. [2 ]
Cieri, N. [1 ]
Ponzoni, M. [1 ]
Ciceri, F. [1 ]
Bordignon, C. [3 ]
Holmes, M. [2 ]
Gregory, P. [2 ]
Naldini, L. [1 ]
Bonni, C. [1 ]
机构：
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
[2] Sangamo Biosci, Richmond, CA USA
[3] Molmed, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P050
引用
收藏
页码：S143 / S143
页数：1
相关论文
共 50 条
  • [31] Uninterrupted Mobilization and Transplantation Procedure with Non-cryopreserved Yield is Feasible without Increasement of Complication Risk in Multiple Myeloma Patients
    Ozkurt, Zubeyde Nur
    Dikyar, Ayse Asena
    Yegin, Zeynep Arzu
    Kaynar, Lale Aydin
    Karacaoglu, Ozlem
    Ates, Emin
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 555 - 556
  • [32] Genome editing of the susceptibility gene ZmNANMT confers multiple disease resistance without agronomic penalty in maize
    Li, Ya-Jie
    Gu, Jin-Ming
    Ma, Shijun
    Xu, Yang
    Liu, Mengjie
    Zhang, Chuang
    Liu, Xiangguo
    Wang, Guan-Feng
    PLANT BIOTECHNOLOGY JOURNAL, 2023, 21 (08) : 1525 - 1527
  • [33] Gene Editing and Multi-Omics Reveal Novel Metabolic Vulnerabilities in t(4;14)-Associated Multiple Myeloma
    Sobh, Amin
    Kaestner, Charlotte L.
    Riva, Alberto
    Vasan, Karthik
    Patel, Alisha
    Surapaneni, Greeshma
    Poullard, Janai
    Encinas, Elena
    Bennett, Richard Lynn
    Mitsiades, Constantine S.
    Boise, Lawrence H.
    Chandel, Navdeep S.
    Licht, Jonathan D.
    BLOOD, 2022, 140 : 5911 - 5912
  • [34] A Protocol for Genetic Evaluation of Patients with Multiple Colorectal Adenomas and without Evidence of APC Gene Mutation
    Rosner, Guy
    Rozen, Paul
    Bercovich, Dani
    Shochat, Chen
    Solar, Irit
    Strul, Hana
    Kariv, Revital
    Halpern, Zamir
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2010, 12 (09): : 549 - 553
  • [35] In vivo modeling of clonal competition using CRISPR-based gene editing reveals novel fitness variables in multiple myeloma
    Shen, Yujia
    Manier, Salomon
    Tahri, Sabrin
    Berrios, Brianna
    Sklavenitis-Pistofidis, Romanos
    Ghobrial, Irene
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E110 - E110
  • [36] In Vivo Modeling of Clonal Competition Using CRISPR-Based Gene Editing Reveals Novel Fitness Variables in Multiple Myeloma
    Shen, Yujia
    Manier, Salomon
    Tahri, Sabrin
    Berrios, Brianna
    Zavidij, Oksana
    Park, Jihye
    Pistofidis, Romanos
    Ghobrial, Irene M.
    BLOOD, 2018, 132
  • [37] TCRαβ/CD19 depleted and IL-15 stimulated donor cell infusions can exert anti-tumor effects after allosct without inducing GVHD in vitro and in vivo
    Lang, Anne-Marie
    Hundsdoerfer, Patrick
    Heubach, Florian
    Ribeiro, Emmanuelle Moraes
    Rabsteyn, Armin
    Kuenkele, Annette
    Schlegel, Patrick
    Seitz, Christian
    Doering, Michaela
    Schumm, Michael
    Eggert, Angelika
    Handgretinger, Rupert
    Lang, Peter
    Schulte, Johannes
    BONE MARROW TRANSPLANTATION, 2019, 54 : 43 - 44
  • [38] Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates
    Huda, Taha I.
    Mihyu, Moody
    Gozlan, Etienne C.
    Arndt, Mary F.
    Diaz, Michael J.
    Zaman, Saif
    Chobrutskiy, Boris I.
    Blanck, George
    LEUKEMIA & LYMPHOMA, 2021, 62 (07) : 1711 - 1720
  • [39] Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study
    Keen, Carol
    Skilbeck, Julie
    Ross, Helen
    Smith, Lauren
    Collins, Karen
    Dixey, Joanne
    Walters, Stephen
    Greenfield, Diana M.
    Snowden, John A.
    Mawson, Susan
    BMJ OPEN, 2018, 8 (03):
  • [40] Targeting HLA.A2-restricted MDM2 (81-88) epitope as a new antigen for TCR gene therapy of multiple myeloma
    Amann, E.
    Antunes, E.
    Jacobi, B.
    Theobald, M.
    Echchannaoui, H.
    Oncology Research and Treatment, 2015, 38 : 37 - 37
12345